Effect of renin-angiotensin system blockade on calcium channel blocker-associated peripheral edema.

[1]  N. Laird,et al.  Meta-analysis in clinical trials. , 1986, Controlled clinical trials.

[2]  J. Ménard,et al.  Converting-enzyme inhibition buffers the counter-regulatory response to acute administration of nicardipine. , 1987, British journal of clinical pharmacology.

[3]  Amlodipine.: Long-Term Natriuretic and Antihypertensive Activity in Spontaneously Hypertensive Rats with Developing and Established Hypertension , 1988 .

[4]  F. Cappuccio,et al.  Effects of amlodipine on urinary sodium excretion, renin-angiotensin-aldosterone system, atrial natriuretic peptide and blood pressure in essential hypertension. , 1991, Journal of human hypertension.

[5]  P. Fitscha,et al.  Evaluation of Isradipine and Captopril Alone or in Combination for the Treatment of Hypertension , 1991, Journal of cardiovascular pharmacology.

[6]  Comparison of the efficacy and safety of trandolapril and nifedipine SR in mild-to-moderate hypertension. Investigator Study Group. , 1994, Journal of cardiovascular pharmacology.

[7]  T. Fagan.  Remembering the lessons of basic pharmacology. , 1994, Archives of internal medicine.

[8]  Comparison of the Efficacy and Safety of Trandolapril and Nifedipine SR in Mild‐to-Moderate Hypertension , 1994 .

[9]  K. Ferdinand,et al.  Additive effects of verapamil and enalapril in the treatment of mild to moderate hypertension. , 1995, American journal of hypertension.

[10]  Antihypertensive Effects of Moexipril, a New ACE Inhibitor, as Add‐On Therapy to Nifedipine in Patients with Essential Hypertension , 1995, Journal of cardiovascular pharmacology.

[11]  W. Frishman,et al.  Comparison of Amlodipine and Benazepril Monotherapy to Amlodipine Plus Benazepril In Patients with Systemic Hypertension: A Randomized, Double‐Blind, Placebo‐Controlled, Parallel‐Group Study , 1995, Journal of clinical pharmacology.

[12]  B. Rangoonwala,et al.  Ramipril and felodipine: a comparison of the efficacy and safety of monotherapy versus combination therapy. , 1996, Current medical research and opinion.

[13]  E. Kuschnir,et al.  Treatment of patients with essential hypertension: amlodipine 5 mg/benazepril 20 mg compared with amlodipine 5 mg, benazepril 20 mg, and placebo. , 1996, Clinical therapeutics.

[14]  G. Smith,et al.  Bias in meta-analysis detected by a simple, graphical test , 1997, BMJ.

[15]  J. Robbins,et al.  Combined enalapril and felodipine extended release (ER) for systemic hypertension. Enalapril-Felodipine ER Factorial Study Group. , 1997, The American journal of cardiology.

[16]  B. Tomlinson,et al.  Additive effects of diltiazem and lisinopril in the treatment of elderly patients with mild-to-moderate hypertension. , 1997, American journal of hypertension.

[17]  F. Messerli,et al.  Effects of verapamil and trandolapril in the treatment of hypertension. Trandolapril Study Group. , 1998, American journal of hypertension.

[18]  I. Olkin,et al.  Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement , 1999, The Lancet.

[19]  J. Massaro,et al.  Antihypertensive profiles with ascending dose combinations of ramipril and felodipine ER. , 1999, Clinical and experimental hypertension.

[20]  B. Karlberg.  Efficacy and Safety of a New Long-acting Drug Combination, Trandolapril/Verapamil as Compared to Monotherapy in Primary Hypertension , 2000 .

[21]  Giuseppe Mancia,et al.  Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT) , 2000, The Lancet.

[22]  S. Oparil,et al.  Comparison of efficacy and side effects of combination therapy of angiotensin-converting enzyme inhibitor (benazepril) with calcium antagonist (either nifedipine or amlodipine) versus high-dose calcium antagonist monotherapy for systemic hypertension. , 2000, The American journal of cardiology.

[23]  Susan Eastwood,et al.  Mejora de la calidad de los informes de los metaanálisis de los ensayos clínicos controlados: el acuerdo QUOROM , 2000 .

[24]  F. Messerli.  Vasodilatory edema: A common side effect of antihypertensive therapy , 2002, American journal of hypertension.

[25]  M. Mariani,et al.  Calcium channel blockers, postural vasoconstriction and dependent oedema in essential hypertension , 2001, Journal of Human Hypertension.

[26]  S. Oparil,et al.  Once-daily treatment of patients with hypertension: a placebo-controlled study of amlodipine and benazepril vs amlodipine or benazepril alone , 2001, Journal of Human Hypertension.

[27]  J. Fink,et al.  Pilot study to evaluate a water displacement technique to compare effects of diuretics and ACE inhibitors to alleviate lower extremity edema due to dihydropyridine calcium antagonists. , 2001, American journal of hypertension.

[28]  Pedal edema--not all dihydropyridine calcium antagonists are created equal. , 2002, American journal of hypertension.

[29]  B. Davis,et al.  Success and predictors of blood pressure control in diverse North American settings: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). , 2002, Journal of clinical hypertension.

[30]  Douglas G Altman,et al.  Interaction revisited: the difference between two estimates , 2003, BMJ : British Medical Journal.

[31]  K. Jamerson,et al.  Initial angiotensin-converting enzyme inhibitor/calcium channel blocker combination therapy achieves superior blood pressure control compared with calcium channel blocker monotherapy in patients with stage 2 hypertension. , 2004, American journal of hypertension.

[32]  G. Mancia,et al.  Effects of the Combination of Low-Dose Nifedipine GITS 20 mg and Losartan 50 mg in Patients with Mild to Moderate Hypertension , 2004, Journal of cardiovascular pharmacology.

[33]  G. Bakris,et al.  Amlodipine/benazepril combination therapy for hypertensive patients nonresponsive to benazepril monotherapy. , 2004, American journal of hypertension.

[34]  D. Pittrow,et al.  Evaluation of the Efficacy and Tolerability of a Low-Dose Combination of Isradipine and Spirapril in the First-Line Treatment of Mild to Moderate Essential Hypertension , 1997, Cardiovascular Drugs and Therapy.

[35]  M. Gatlin,et al.  Efficacy of Combination Therapy for Systolic Blood Pressure in Patients With Severe Systolic Hypertension: The Systolic Evaluation of Lotrel Efficacy and Comparative Therapies (SELECT) Study , 2005, Journal of clinical hypertension.

[36]  M. Gatlin,et al.  Efficacy of combination therapy with amlodipine besylate/benazepril hydrochloride for lowering systolic blood pressure in stage 2 hypertension. , 2006, The American journal of geriatric cardiology.

[37]  T. Saruta,et al.  Controlled Release Nifedipine and Valsartan Combination Therapy in Patients with Essential Hypertension: The Adalat CR and Valsartan Cost-Effectiveness Combination (ADVANCE-Combi) Study , 2006, Hypertension Research.

[38]  G. Feitosa,et al.  Estudo "LOTHAR": avaliação de eficácia e tolerabilidade da combinação fixa de anlodipino e losartana no tratamento da hipertensão arterial primária , 2006 .

[39]  M. Munger,et al.  Antihypertensive Efficacy of the Oral Direct Renin Inhibitor Aliskiren as Add‐On Therapy in Patients Not Responding to Amlodipine Monotherapy , 2007, Journal of clinical hypertension.

[40]  S. Bangalore,et al.  Fixed-dose combinations improve medication compliance: a meta-analysis. , 2007, The American journal of medicine.

[41]  A. Dominiczak,et al.  2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension. , 2007, Journal of hypertension.

[42]  T. Philipp,et al.  Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension. , 2007, Clinical therapeutics.

[43]  A. Bagchi,et al.  Results of a comparative, phase III, 12-week, multicenter, prospective, randomized, double-blind assessment of the efficacy and tolerability of a fixed-dose combination of telmisartan and amlodipine versus amlodipine monotherapy in Indian adults with stage II hypertension. , 2007, Clinical therapeutics.

[44]  Tiziano Perrone,et al.  Effect on the development of ankle edema of adding delapril to manidipine in patients with mild to moderate essential hypertension: a three-way crossover study. , 2007, Clinical therapeutics.

[45]  Ho-Ming Su,et al.  An eight‐week, multicenter, randomized, double‐blind study to evaluate the efficacy and tolerability of fixed‐dose amlodipine/benazepril combination in comparison with amlodipine as first‐line therapy in Chinese patients with mild to moderate hypertension , 2008, Blood pressure. Supplement.

[46]  M. Melino,et al.  The combination of olmesartan medoxomil and amlodipine besylate in controlling high blood pressure: COACH, a randomized, double-blind, placebo-controlled, 8-week factorial efficacy and safety study. , 2008, Clinical therapeutics.

[47]  G. Bakris,et al.  Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. , 2008, The New England journal of medicine.

[48]  M. Destro,et al.  Efficacy and safety of amlodipine/valsartan compared with amlodipine monotherapy in patients with stage 2 hypertension: a randomized, double-blind, multicenter study: the EX-EFFeCTS Study. , 2008, Journal of the American Society of Hypertension : JASH.

[49]  D. Altman,et al.  Assessing Risk of Bias in Included Studies , 2008 .

[50]  B. Filho,et al.  An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study. , 2008, Clinical therapeutics.

[51]  A. Salvetti,et al.  The combination of amlodipine/valsartan 5/160 mg produces less peripheral oedema than amlodipine 10 mg in hypertensive patients not adequately controlled with amlodipine 5 mg , 2009, International journal of clinical practice.

[52]  H. Schunkert,et al.  Efficacy and tolerability of amlodipine/valsartan combination therapy in hypertensive patients not adequately controlled on amlodipine monotherapy , 2009, Current medical research and opinion.

[53]  P. Ferrari,et al.  Results of a meta-analysis comparing the tolerability of lercanidipine and other dihydropyridine calcium channel blockers. , 2009, Clinical therapeutics.

[54]  J. Flack,et al.  Efficacy and safety of initial combination therapy with amlodipine/valsartan compared with amlodipine monotherapy in black patients with stage 2 hypertension: the EX-STAND study , 2009, Journal of Human Hypertension.

[55]  R. Guthrie,et al.  Original Research: Telmisartan plus Amlodipine in Patients with Moderate or Severe Hypertension: Results from a Subgroup Analysis of a Randomized, Placebo-Controlled, Parallel-Group, 4 × 4 Factorial Study , 2009, Postgraduate medicine.

[56]  M. Volpe,et al.  Efficacy and Tolerability of Olmesartan Medoxomil Combined with Amlodipine in Patients with Moderate to Severe Hypertension after Amlodipine Monotherapy , 2009, Clinical Drug Investigation.

[57]  R. Guthrie,et al.  Results of Treatment With Telmisartan‐Amlodipine in Hypertensive Patients , 2009, Journal of clinical hypertension.

[58]  N. Poulter,et al.  Compliance, Safety, and Effectiveness of Fixed-Dose Combinations of Antihypertensive Agents: A Meta-Analysis , 2010, Hypertension.